Freedland Cory S. 4
4 · Neurogene Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
Freedland Cory S.
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
[F1]2026-02-20+12,050→ 12,050 totalExercise: $17.64Exp: 2036-02-20→ Common Stock (12,050 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the total shares monthly beginning March 20, 2026 until the option is fully vested on February 20, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Signature
/s/ Donna M. Cochener, Attorney-in-fact for Cory S. Freedland|2026-02-24